Support Provided, Including a Maximum Guarantee Limit of 10 Billion Won

The Korea Technology Finance Corporation (KOTEC) announced on the 26th that it had awarded a "Kibo-Star Valley Enterprise" certificate to the bio company ANJ Science.


The certificate award ceremony was held on the same day at COEX in Gangnam-gu, Seoul, during the "Biohealth Innovative Startup Growth Support Program," which was co-hosted with the Korea Institute of Toxicology (KIT).


This event was organized to identify promising companies in the bio sector with high growth potential and to support their development through customized financial support. Park Kyung-soon, Head of the Chungcheong Regional Headquarters at KOTEC, Kim In-sook, Head of the Bio-Innovation and Growth Strategy Division at KIT, and Lee Yeji, Head of Division at ANJ Science, were in attendance.

On the 26th, at COEX in Gangnam-gu, Seoul, representatives from the Korea Technology Finance Corporation and ANJ Science are taking a commemorative photo at the "Biohealth Innovation Startup Growth Support Program." Korea Technology Finance Corporation

On the 26th, at COEX in Gangnam-gu, Seoul, representatives from the Korea Technology Finance Corporation and ANJ Science are taking a commemorative photo at the "Biohealth Innovation Startup Growth Support Program." Korea Technology Finance Corporation

View original image

KOTEC offers Kibo-Star Valley Enterprises support tailored to their growth stage. This includes: ▲ a pre-assigned guarantee limit (ranging from 3 billion to 10 billion won), ▲ a preferential guarantee rate (95%), and ▲ a 0.5 percentage point reduction in guarantee fees.


ANJ Science, established in 2021, is a company engaged in research and development in medicine and pharmacology. By utilizing large-scale synthesis technology for thiopeptide—a natural antibiotic substance—the company is developing new drugs to address antibiotic-resistant bacteria.



Park Kyung-soon, Head of the Chungcheong Regional Headquarters, stated, "It is significant that we have linked the promising bio companies we discovered through the collaboration between KOTEC and KIT to follow-up financial support. We will continue to help ensure that the technology development achievements of innovative companies lead to commercialization and market entry."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing